Psoriatic arthritis is a chronic autoimmune inflammatory disorder that causes inflammation, swelling, and stiffness at any joint of the body. Psoriatic arthritis is a progressive form of psoriasis, characterized by the itchy, scaly red patches on the skin.
This report contains market size and forecasts of Psoriatic Arthritis Therapeutics Drug in global, including the following market information:
Global Psoriatic Arthritis Therapeutics Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Psoriatic Arthritis Therapeutics Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Psoriatic Arthritis Therapeutics Drug companies in 2021 (%)
The global Psoriatic Arthritis Therapeutics Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NF Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Psoriatic Arthritis Therapeutics Drug include AbbVie, Janssen Biotech, Novartis, Amgen, CELGENE CORPORATION, Pfizer, Eli Lilly, UCB and Biogen and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Psoriatic Arthritis Therapeutics Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psoriatic Arthritis Therapeutics Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psoriatic Arthritis Therapeutics Drug Market Segment Percentages, by Type, 2021 (%)
NF Inhibitors
Interleukin Inhibitors
PDE4 Inhibitors
Others
Global Psoriatic Arthritis Therapeutics Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psoriatic Arthritis Therapeutics Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Psoriatic Arthritis Therapeutics Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psoriatic Arthritis Therapeutics Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psoriatic Arthritis Therapeutics Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Psoriatic Arthritis Therapeutics Drug revenues share in global market, 2021 (%)
Key companies Psoriatic Arthritis Therapeutics Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Psoriatic Arthritis Therapeutics Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Janssen Biotech
Novartis
Amgen
CELGENE CORPORATION
Pfizer
Eli Lilly
UCB
Biogen
Bristol-Myers Squibb